CORRECTION article

Front. Oncol., 10 January 2023

Sec. Breast Cancer

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1118572

Corrigendum: TGF-β1 promotes human breast cancer angiogenesis and malignant behavior by regulating endothelial-mesenchymal transition

  • 1. Department of Rheumatology and Immunology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China

  • 2. Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, China

  • 3. Department of Rheumatology, Shantou University Medical College, Shantou, China

  • 4. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China

  • 5. Department of Endocrinology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China

Error in Figure/Table

In the published article, there was an error in Figure 1 High expression of MVD predicted unfavorable prognosis of IDC patients. as published. In Figure 1B, the title of X axis was “Specificity”, it should be corrected to “1-Specificity”. The corrected Figure 1 High expression of MVD predicted unfavorable prognosis of IDC patients. and its caption appear below.

Figure 1

In the published article, there was an error in Figure 2 MVD level is positively correlated with EndMT markers in breast cancer. as published. In Figure 2A, B, the red “#” and green “*” were missing. The corrected Figure 2 MVD level is positively correlated with EndMT markers in breast cancer. and its caption appear below.

Figure 2

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

TGF-β1, EndMT, angiogenesis, breast cancer, BCSLC, dorsal skinfold window chamber

Citation

Li Z-X, Chen J-X, Zheng Z-J, Cai W-J, Yang X-B, Huang Y-Y, Gong Y, Xu F, Chen Y-S and Lin L (2023) Corrigendum: TGF-β1 promotes human breast cancer angiogenesis and malignant behavior by regulating endothelial-mesenchymal transition. Front. Oncol. 12:1118572. doi: 10.3389/fonc.2022.1118572

Received

07 December 2022

Accepted

12 December 2022

Published

10 January 2023

Volume

12 - 2022

Edited and reviewed by

Donghong Zhang, Emory University, United States

Updates

Copyright

*Correspondence: Ling Lin, ; Yong-Song Chen,

†These authors have contributed equally to this work

This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics